Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole PK and Safety in Children with Leukemia
NCT04194086Phase 2Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Nov 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in invasive fungal disease (IFD), sponsored by Southern Medical University Zhujiang Hospital. Started Nov 2018; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT04194086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194086.